Adverse effect rates with Pfizer-BioNTech and Moderna COVID-19 vaccinesActive surveillance system collects near–real-time data from mRNA COVID-19 vaccine recipients in the United States. To test or not to test?While some pharmacists feel it’s a rewarding opportunity, lack of time and resources prevent others from embracing a role as community COVID-19 testers Untreated chronic diseases escalate in Canada during COVID-19 pandemic Report estimates that more than 130,000 Canadians with undiagnosed chronic diseases did not begin treatment in 2020. New HIV vaccine concept shows promise COVID-19 vaccination may influence breast cancer screening exams Guidance on scheduling breast cancer screening exams relative to COVID-19 vaccination dates and managing axillary adenopathy after recent COVID-19 vaccination New warning about risk for Guillain-Barré syndrome after Shingrix administration US Food and Drug Administration requires warning about GBS be added to the prescribing information for Shingrix (herpes zoster vaccine) Avoid simultaneous administration of COVID-19 and non-COVID-19 vaccines Precautionary recommendation from NACI based on lack of data on possible side effects. Five-day treatment effective for community-acquired pneumonia in children Canadian study finds 5-day high-dose amoxicillin therapy comparable to standard 10 days in children with CAP not requiring hospitalization. How well do current COVID-19 vaccines protect against COVID-19 variants? A look at what is currently known and unknown about vaccine efficacy against COVID-19 variants of concern. Be alert for possible delayed local reactions with Moderna COVID-19 vaccine First Previous 69 70 71 72 73 Next Last
